{"id":446,"date":"2019-03-14T11:57:09","date_gmt":"2019-03-14T10:57:09","guid":{"rendered":"http:\/\/www.mammaprint.cz\/blueprint\/"},"modified":"2019-03-14T12:36:30","modified_gmt":"2019-03-14T11:36:30","slug":"blueprint","status":"publish","type":"page","link":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/","title":{"rendered":"BluePrint"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.47&#8243; custom_padding=&#8221;54px|0px|22px|0px|false|false&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row _builder_version=&#8221;3.0.48&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;1_3&#8243;][et_pb_image src=&#8221;http:\/\/www.mammaprint.cz\/wp-content\/uploads\/2019\/01\/Agendia_BluePrint_Logo-1.jpg&#8221; align=&#8221;center&#8221; _builder_version=&#8221;3.19.4&#8243; max_width=&#8221;75%&#8221; module_alignment=&#8221;center&#8221; \/][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.8em&#8221;]<\/p>\n<h2><strong>\u010co je BluePrint?<\/strong><\/h2>\n<p>BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov:<\/p>\n<ul>\n<li>Lumin\u00e1lny<\/li>\n<li>HER2<\/li>\n<li>Baz\u00e1lny.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; specialty=&#8221;off&#8221; prev_background_color=&#8221;#ffffff&#8221; next_background_color=&#8221;#ffffff&#8221; _builder_version=&#8221;3.19.4&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_start=&#8221;#094fa4&#8243; background_color_gradient_end=&#8221;#16c1f4&#8243; background_color_gradient_direction=&#8221;70deg&#8221;][et_pb_row _builder_version=&#8221;3.19.4&#8243; module_alignment=&#8221;center&#8221; make_equal=&#8221;on&#8221;][et_pb_column type=&#8221;1_3&#8243;][et_pb_number_counter _builder_version=&#8221;3.19.4&#8243; number=&#8221;21&#8243; background_layout=&#8221;dark&#8221; title_level=&#8221;h4&#8243; title_font=&#8221;|700|||||||&#8221; number_text_color=&#8221;#ffffff&#8221; number_font=&#8221;|700|||||||&#8221; number_font_size=&#8221;100&#8243; title_font_size=&#8221;20&#8243; animation_style=&#8221;fade&#8221; custom_margin=&#8221;45px|||&#8221; \/][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_text_color=&#8221;#ffffff&#8221; text_font_size=&#8221;19px&#8221;]<\/p>\n<p>V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami MammaPrint a BluePrint ku spresneniu predpovede progn\u00f3zy pacienta a pomoci pri v\u00fdbere vhodnej lie\u010dby. 21% pacientov bolo preklasifikovan\u00fdch ako MAmmaPrint n\u00edzkorizikov\u00fdch, BluePrint lumin\u00e1lny typA  a uk\u00e1zali tak mal\u00fd, pokia\u013e v\u00f4bec nejak\u00fd efekt chemoterapie pre pacientov.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.47&#8243; custom_padding=&#8221;12px|0px|54px|0px|false|false&#8221; prev_background_color=&#8221;#000000&#8243;][et_pb_row _builder_version=&#8221;3.0.48&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243;]<\/p>\n<p>V kombin\u00e1cii s MammaPrint m\u00f4\u017eu by\u0165 pacientky zaraden\u00e9 do nasleduj\u00facich \u0161tyroch podtypov:<\/p>\n<ul>\n<li>Lumin\u00e1lny\/s n\u00edzkym rizikom (lumin\u00e1lny A)<\/li>\n<li>Lumin\u00e1lny\/s vysok\u00fdm rizikom (lumin\u00e1lny B)<\/li>\n<li>HER2<\/li>\n<li>Baz\u00e1lny<\/li>\n<\/ul>\n<p><strong>Ako prebieha testovanie?? <\/strong><\/p>\n<p>Testy MammaPrint a BluePrint je mo\u017en\u00e9 vykona\u0165 naraz a na jednej vzorke tkaniva. V\u00fdsledky s\u00fa k dispoz\u00edcii do desiatich dn\u00ed.<\/p>\n<p><strong>Komu je BluePrint ur\u010den\u00fd?<\/strong><\/p>\n<p>Obidva testy, MammaPrint aj BluePrint s\u00fa navrhnut\u00e9 pre \u017eeny v\u0161etk\u00fdch vekov\u00fdch kateg\u00f3ri\u00ed, ktor\u00e9:<\/p>\n<ul>\n<li>S\u00fa novo diagnostikovan\u00e9 s invaz\u00edvnym karcin\u00f3mom prsn\u00edka v po\u010diato\u010dnom \u0161t\u00e1diu (\u0161t\u00e1dium I alebo II)<\/li>\n<li>Maj\u00fa negat\u00edvne lymfatick\u00e9 uzliny alebo 1-3 pozit\u00edvne lymfatick\u00e9 uzliny<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami MammaPrint [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-446","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/comments?post=446"}],"version-history":[{"count":3,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446\/revisions"}],"predecessor-version":[{"id":472,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446\/revisions\/472"}],"wp:attachment":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/media?parent=446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}